Actemra 160mg, a drug known scientifically as tocilizumab, is a a potent pharmaceutical agent primarily utilized for the management of rheumatoid arthritis. This effective substance operates by blocking the activity of interleukin-6 (IL-6), a communication protein crucial in the inflammatory process. Additionally, Actemra has shown efficacy in the